References
Ackerman JH, Grove TH, Wong GG, et al (1980): Mapping of metabolites in whole animals by 31P nuclear magnetic resonance spectroscopy. Nature 283:167-170.
Akbarian S, Bunney W E, Potkin S G, Wigal S B, Hagman J O, Sandman C A, Jones E G (1993): Altered distribution of nicotinamide-adenine dinucleotide phosphatase-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Archive of Psychiatry 50: 169.
Akbarian S, Vinuela A, Kim J J, Potkin S G, Bunney W E, Jones E G (1993): Distorted distribution of nicotinamide-adenine dinucleotide phosphatase-diaphorase neurons in temporal lobe of schizophrenics implies disturbances of cortical development. Archive of Psychiatry 50:178.
Allen DN, Seaton BE, Goldstein G, Sanders RD, Gurklis JA Jr, Peters JL, van Kammen DP (2000): Neuroanatomic differences among cognitive and symptom subtypes of schizophrenia. Journal of Nervous and Mental Disorder. 188(6):381-4.
Ambrus E, Szekeres G, Keri S, Csernay L, Janka Z, Pavics L (1999): [Regional cerebral blood flow changes in schizophrenic patients detected by SPECT studies under resting and active conditions].[Article in Hungarian] (Abstract) Orv Hetil ;140(32):1783-6.
Andreasen N C (1988): Brain imaging: Applications in psychiatry. Science 239:1381.
Andreasen NC, O'Leary DS, Cizadlo T, et al (1996): Schizophrenia and cognitive dysmetria: A positron-emission tomography study of dysfunctional prefrontal-thalamic-Cerebellar circuitry. Proceedings of the National Academy of Sciences of the United States of America 93:9985-9990 .
Arango C, Crespo-Facorro B (1999): Schizophrenia: a brain disease. I. Structural neuroimaging.: Actas Espaolas de Psiquiatra; 27(6):398-407 (abstract).
Ariel RN, Golden CJ, Berg RA, Quaife MA, DirksonJW, Forsell T, Wilson J, Garber B (1983): Regional cerebral blood flow in schizophrenics. Archive of General Psychiatry. 40:258-263.
Atlas of Brain perfusion (1995): , information on SPECT images through www.bwh.harvard.edu.
Bajc M, Medved V, Basic M, Topuzovic N, Babic D, (1989):Cerebral perfusion inhomogeneities in schizophrenia demonstrated with single-photon emission computed tomography and Tc99m-hexamethylpropyleneamineoxim. Acta Psychiatra Scandinavia.; 80:427-433.
Bartley A J, Jones D W, Torrey E F, Zigun J R, Weinberger D R (1993): Sylvian fissure asymmetries in monozygotic twins: A test of laterality in schizophrenia. Biological Psychiatry. 34: 853.
Beckmann H (1999): Developmental malformations in cerebral structures of schizophrenic patients. European Archives of Psychiatry and Clinical Neuroscience; 249 Supplement. 4:44-7.
Berman KF, Illowsky, BP, Weinberger DR, (1998): Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, IV: further evidence for regional and behavioral specificity. Archive of General Psychiatry; 45:616-622.
Berman KF, Zec RF, Weinberger DR.(1986):Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia, the role of neuroleptic treatment, attention and mental effort. Archive of General Psychiatry; 43:126-135.
Bertolino A, Nawroz S, Mattay VS, et al (1996): Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. American Journal of Psychiatry. 153:1554-1563.
Bigliani V, Pilowsky LS (1999): In vivo neuropharmacology of schizophrenia. British Journal of Psychiatry Supplement ;(38):23-33.
Blackwood DH, Glabus MF, Dunan J, O'Carroll RE, Muir WJ, Ebmeier KP (1999): Altered cerebral perfusion measured by SPECT in relatives of patients with schizophrenia. Correlations with memory and P300. British Journal of Psychiatry; 175:357-66.
Bogerts B (1999): The neuropathology of schizophrenic diseases: historical aspects and present knowledge. European Archives of Psychiatry and Clinical Neuroscience; 249 Supplement 4:2-13.
Bolinger L, Lenkinski RE: Localization in clinical NMR spectroscopy: In Berliner LJ, Reuben J (eds) (1992): Biological Magnetic Resonance 11 In Vivo Spectroscopy. New York, Plenum Press, pp 1-53
Born J (1999): Brain morphology in adolescents at genetic risk for schizophrenia assessed by qualitative and quantitative magnetic resonance imaging. Schizophrenia Research; 40(1):81-4.
Breier A, et al (1992): Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Archive of Psychiatry 49:921-926 .
Bremner JD, Baldwin R, Horti A, Staib LH, et al (1999): Quantitation of benzodiazepine receptor binding with PET [11C] iomazenil and SPECT [123I]iomazenil preliminary results of a direct comparison in healthy human subjects. Psychiatry Research.; 91(2): 79-91.
Brodie JD (1997): Imaging for the clinical psychiatrist: Facts, fantasies, and other musings. Am J Psychiatry 153:145-149.
Buchanan RW, et al (1993): Structural abnormalities in deficit and nondeficit schizophrenia. American Journal of Psychiatry 150:59-65.
Buchli R, Martin E, Boesiger P, et al (1994): Developmental changes of phosphorus metabolite concentrations in the human brain: A 31 P magnetic resonance spectroscopy study in vivo. Pediatric Research 35:431-435.
Buchsbaum MS (1990): The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophrenia Bulletin 16:379-389.
Buchsbaum MS, Delisi LE, Holcomb HH, Capelletti J, et al (1984): Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Archive of General Psychiatry; 41:1159-1166.
Buchsbaum MS, et al (1996): PET and MRI of the thalamus in never-medicated patients with schizophrenia. American Journal of Psychiatry 153:191-199.
Buchsbaum MS, Haier RJ, Potkin SG, et al (1992): Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Archive of Psychiatry 49:935-942.
Buchsbaum MS, Ingvar DH, Kessier R, Waters RN, Capelletti J, Kammen DP, King C, Johnson J, Manning RC, Flynn RW, Mann LS, Bunney WE, Sokoloff L (1982): Cerebral glucography with positron tomography. Archive of General Psychiatry; 39:251-259.
Buchsbaum MS, Nuechterlein KH, Haier RJ, et al (1990): Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. British Journal of Psychiatry 156:216-227.
�Buchsbaum MS, Someya T, Teng CT, et al (1996): PET and MRI of the thalamus in never-medicated patients with schizophrenia. American Journal of Psychiatry 153:191-199.
Buckley PF, Friedman L, Wu D, et al (1997): Functional magnetic resonance imaging in schizophrenia: Initial methodology and evaluation of the motor cortex. Psychiatry Research (Neuroimaging) 74:13-23.
Buckley PF, Moore C, Long H, et al (1994): 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: Clinical, neurodevelopmental, and cognitive correlates. Biological Psychiatry 36:792-800.
Busatto GF, Costa DC, Ell PJ, et al (1994): Regional cerebral blood flow (rCBF) in schizophrenia during verbal memory activation: A 99m Tc-HMPAO single photon emission tomography (SPET) study. Psychological Medicine 24:463-472.
Bustany P, Henry JF, Rotrou JD, Signoret P, Cabania E, Zarifian E, Siegler M, Darion JM, Crouzel C, Soussaline F, Comar D, (1985):Correlations between clinical state and positron emission tomography measurement of local brain protein synthesis in Alzheimer's dementia, Parkinson's disease, schizophrenia, and gliomas. In: Greitz T, Ingvar DH, Widen I, eds. The Metabolism of the Human Brain Studied With Positron Emission Tomography. New York, NY: Raven Press; 241-251.
Ceballos C, Baringo T, Carrero P, Ventura T, Pelegrin C (1997): Chronic schizophrenia: validity of the study of regional cerebral blood flow through cerebral SPECT. Review of Neurology; 25(145):1346-1349.
Chahrol H, Guell A, Bes A, Moron P, (1986):Cerebral blood flow in schizophrenic adolescents. American Journal of Psychiatry. 143:130.
Chakos MH, Lieberman JA, Bilder RM, et al (1994): Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. American Journal of Psychiatry 151:1430-1436.
Chen RY, Chen E, Ho WY (2000): A five-year longitudinal study of the regional cerebral metabolic changes of a schizophrenic patient from the first episode using Tc-99m HMPAO SPECT. European Archives of Psychiatry and Clinical Neuroscience; 250(2):69-72.
Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999): Limbic activation during cue-induced cocaine craving. American Journal of Psychiatry 156:11.
Cleghorn JM, Garnett ES, Nahmias C, Firman G, Brown CM, Kapalan RD, Szechtman H, Szechtman B, (1989): increased frontal and reduced pariet al glucose metabolism in acute untreated schizophrenia. Psychiatry Research; 28: 119-133.
Cohen J (1977): Statistical power analysis for the behavioral sciences. New York, Academic Press .
Cohen RM, Gross M, Nordahl TE, Delisi LE, Holcomb HH, King AC, Morihisa JM, Pickar D (1987): Dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Life Science; 40:2031-2039.
Cohen RM, Semple WE, Gross M, et al (1989): Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology 2:241-254.
Cohen RM, Semple WE, Gross M, Nordahl TE, King AC, Pickar D, Post RM, (1989): Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology�2: 241-254.
Conca A, Fritzsche H, Peschina W, Konig P, Swoboda E, Wiederin H, Haas C (1998): Preliminary findings of simultaneous 18F-FDG and 99mTc-HMPAO SPECT in patients with depressive disorders at rest: differential correlates with ratings of anxiety.
Cormack A.M. (1963): Representation of a function by its line integrals, with some radiological applications, Journal of Applied Physiology, vol. 34, pp. 2722-2727.
Costa DC, Pilowsky LS, Ell PJ (1999). Nuclear medicine in neurology and psychiatry. Lancet. 354 (9184):1107-11 .
Crow T (1980) : Aetiology of Schizophrenia . Current opinion in Psychiatry 7: 39-42
Curtis VA, van Os J, Murray RM (2000): The Kraepelinian dichotomy: evidence from developmental and neuroimaging studies. Journal of Neuropsychiatry and Clinical Neurosciences; 12(3):398-405
Daniel DG, et al (1991): Lack of a bimodal distribution of ventricular size in schizophrenia: A gaussian mixture analysis of 1056 cases and controls. Biological Psychiatry 30:887-903
Deicken RF, Calabrese G, Merrin EL, et al (1994): 31 Phosphorus magnetic resonance spectroscopy of the frontal and pariet al lobes in chronic schizophrenia. Biological Psychiatry 36:503-510
Deicken RF, Zhou L, Corwin F, et al (1997): Decreased left frontal lobe N-acetylaspartate in schizophrenia. American Journal of Psychiatry 154:688-690
DeLisi LE, et al (1991): Brain morphology in first-episode schizophrenic-like psychotic patients: A quantitative magnetic resonance imaging study. Biological Psychiatry 29:159-175
Denihan A, Wilson G, Cunningham C, Coakley D, Lawlor BA (2000): CT measurement of medial temporal lobe atrophy in Alzheimer's disease, vascular dementia, depression and paraphrenia. International Journal of Geriatric Psychiatry (4):306-12
Devous MD, Sr, Raese JD, Herman MH, Paulman RG, Gregory RR, Rush , Chehabi H H, Bonte, (1985): Regional cerebral blood flow in schizophrenic patients at rest and during Wisconsin card sort tasks. Journal of Cerebral blood Flow Metabolism; 5(suppl) 5201-5202
Dousse M, Marno H, Ponsin JC, Dinh YT (1988):Cerebral blood flow in schizophrenia. Experimental Neurology; 199:98-111.
Early TS, Reiman EM, Raichle ME, SpitznagelEI (1987): left globus pallidus abnormality in never-medicated patients with schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 84:561-563.
Erbas B, KurnbasarH, Erbengi G, Bekdik C (1990):Tc-99m HMPAC)/SPECT determination of regional cerebral blood flow changes in schizophrenics. Clinical Nuclear Medicine ; 1 2:904-907.
Erkwoh R, Sabri O, Steinmeyer EM, Bull U, Sass H (1997): Psychopathological and SPECT findings in never-treated schizophrenia. Acta Psychiatrica Scandinavia 1997 Jul; 96(1):51-57
Erkwoh R, Sabri O, Willmes K, Steinmeyer EM, Bull U, Sass H (1999): [Aspects of cerebral connectivity in schizophrenia. A comparative CBF study on treated schizophrenics before and after medication]. Fortschr Neurol Psychiatr (abstract); 67(7):318-26
Ernst M, Zametkin AJ, Jones PH, Matochik JA, Pascualvaca D, Cohen RM (1999): High presynaptic dopaminergic activity in children with Tourette's disorder. Journal American Academic Child Adolescent Psychiatry 38:86.
�Farde L, Nordstrom AL, Wiesel FA, et al (1992): PET-analysis of central D1 - and D2 -dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine--relation to extrapyramidal side effects. Archive of Psychiatry. 49:538-544
Farde L, Nyberg S, Oxenstierna G, et al (1995): Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients. British Journal of Clinical Pharmacology Journal Clinical Psychopharmacology 15:195-235
Farde L, Wiesel FA, Stone-Elander S, et al (1990): D2 dopamine receptors in neuroleptic-naive schizophrenic patients: A positron emission tomography study with 11 C raclopride. Archives of Psychiatry 47:213-219
Farkas T, Wolf AP, Jaeger I, Brodie JD, Christman DR, Fowler IS (1984): Regional brain glucose metabolism in chronic schizophrenia: a positron emission transaxial tomographic study. Archive of General Psychiatry; 41:293-300.
Frahm J, Bruhn H, Gyngell ML, et al (1989): Localized proton NMR spectroscopy in different regions of the human brain in vivo: Relaxation times and concentrations of cerebral metabolites. Magnetic Resonance in Medicine 11:47-63
Franzen G, Ingvar DH: :Absence of activation in frontal structures during psychological testing of chronic schizophrenics. Journal of Neurology, Neurosurgery and Psychiatry
Freeman T, Karson CN (1993): The neuropathology of schizophrenia. A focus on the subcortex. Schizophrenia 16:281-293
Frey K. A. (2000) : Neuroimaging In Neurotoxicology. Neurologic Clinics Volume 18 ? Number 3 .
Friston KJ, Frith CD, Fletcher P, et al (1996): Functional topography: Multidimensional scaling and functional connectivity in the brain. Cerebral Cortex 6:156-164
Fujimoto T, Nakano R, Takano T, et al (1992): Study of chronic schizophrenics using 31 P magnetic resonance chemical shift imaging. Acta Psychiatra Scandinavia 86:455-462
Fukuzako H, Takeuchi H, Hokazono Y, et al (1995): Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: Preliminary report. Psychiatry Research 61:193-200
Fukuzako H, Takeuchi K, Ueyama K, et al (1994): 31 P magnetic resonance spectroscopy of the medial temporal lobe of schizophrenic patients with neuroleptic-resistant marked positive symptoms. European Archives of Psychiatry and Clinical Neuroscience 244:236-240
Furlow B, (2000): Radiologic assessment of schizophrenia. Radiology Technology ; 71(5):463-76; quiz 477-80
G. N. Hounsfield (1973): "Computerized transverse axial scanning (tomography). I. Description of system," British Journal Radiology , vol. 46, pp. 1016-1022.
Geraud G, Arne-Bes MC, Guell A, Bes A (1987): Reversibility of hemodynamically hypofrontality in schizophrenia. Journal of Cerebral Blood Flow Metabolism; 709-12.
Goldberg TE, Weinberger DR (1995): A case against subtyping in schizophrenia. Schizophrenia Research; 17(2):147-52.
Guenther W, Moser E, Mueller-Spahn F, von Oefele K, Buell U, Hippius H. (1986): Pathological cerebral blood flow during motorfunction in schizophrenic and endogenous depressed patients. Biological Psychiatry; 21:889- 9.
Guich SM, Buchsbaum MS, Burgwald L, et al (1989): Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia. Schizophrenia Research 2:439-448
Gur RE, et al (1994): Clinical subtypes of schizophrenia: Differences in brain and CSF volume. American Journal of Psychiatry. 151:343-350
Gur RE, Resnick SM, Alavi A, et al (1987): Regional brain function in schizophrenia: I. A positron emission tomography study. Archive of Psychiatry 44:119-125
Gur RE, Resnick SM, Alavi A, Gur RC, Caroff S, Dann R, Silver FL, Saykin AJ, Chawluk JB, Kushner M, Reivich M. (1987): Regional brain function in schizophrenia, 1: a positron emission tomography study. Archive of General Psychiatry; 44:119-125.
Gur RI, Skolnick BE, Gur RC (1983): Brain function in psychiatric disorders, regional cerebral blood flow in medicated schizophrenics. Archive of General Psychiatry; 40:1250-1254.
Guy W (1976): ECDEU Assessment Manual for Psychopharmacology-Revised. U.S. Department of Health, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, pp 218 - 222
Handak C (1995): Technetium-99m ligands. Online Atlas of Brain perfusion SPECT Harvard university
Heckers S, Curran T, Goff D, Rauch SL, Fischman AJ, Alpert NM, Schacter DL (2000): Abnormalities in the thalamus and prefrontal cortex during episodic object recognition in schizophrenia. Biological Psychiatry; 48(7):651-657
Hendren RL, De Backer I, Pandina GJ (2000): Review of neuroimaging studies of child and adolescent psychiatric disorders from the past 10 years. Journal American Academic Child Adolescent Psychiatry.39 (7):815-28.
Hendren RL, Hodde-Vargas J, Yeo RA, et al (1995): Neuropsychophysiological study of children at risk for schizophrenia: A preliminary report. Journal American Academic Child Adolescent Psychiatry 34:1284-1291
Henn FA, Braus DF (1999): Structural neuroimaging in schizophrenia. An integrative view of neuromorphology. European Archives of Psychiatry and Clinical Neuroscience; 249 Suppl 4:48-56
Higashima M, Kawasaki Y, Urata K, Sakai N, Nagasawa T, Koshino Y, Sumiya H, Tonami N, Tsuji S, Matsuda H (2000): Regional cerebral blood flow in male schizophrenic patients performing an auditory discrimination task. Schizophrenia Research 16;42(1):29-39
Higashimar M, Kawasaki Y, Urata K, et al (2000): Regional cerebral blood flow in male schizophrenic patients performing an auditory discrimination task. Schizophrenia Research. 16;42(1):29-39
Holcomb HH, Cascella NG, Thaker GK, et al (1996): Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. American Journal of Psychiatry 153:41-49
Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SCR, Sharma T (1999): Investigation of the effect of typical versus atypical antipsychotics on motor function using functional MRI. Schizophrenia Research; 36: 187-199
Honey GD, Soni W, Bullmore ET, Varatheesan M, Williams SCR, Andrew CM, et al. (1998): Evidence of abnormal lateralisation of motor systems in schizophrenia using functional MRI. Schizophrenia Research; 29: 70.
Honey GD, Soni W, Bullmore ET, Varatheeson M, Williams SCR, Andrew C, et al (1998): Dissecting the components of linguistic processing in schizophrenia using functional MRI. Schizophrenia Research; 29: 65.
Horrobin DF, Glen AIM, Vaddadi K (1994): The membrane hypothesis of schizophrenia. Schizophrenia Research 13:195-207
Houston AS, Kemp PM, Macleod MA, Francis JR, Colohan HA, Matthews HP (1998):Use of significance image to determine patterns of cortical blood flow abnormality in pathological and at-risk groups. Journal Nuclear Medicine ; 39(3):425-30
Hu X, Le TH, Ugurbil K (1997): Evaluation of the early response in fMRI in individual subjects using short stimulus duration. Magnetic Resonance in Medicine 37:877-884
Hyde TM, et al: Neuroanatomical and neurochemical pathology in schizophrenia. In Tasman, Goldfinger SM (eds) (1991): Review of Psychiatry. Washington, DC, American Psychiatric Association Press, pp 7-23
Ingvar DH, Franzen G (1974):Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatra Scandinavia; 50: 425-462.
Innis R B (1998): Single photon emission computed tomography imaging of dopaminergic function presynaptic transporter, postsynaptic receptor, and "intrasynaptic" transmitter. Advances Pharmacology 42:215
Ito H, Halldin C, Farde L (1999): Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique. Journal Nuclear Medicine 40:102.
Jaszczak R.J. (1988): "Tomographic radiopharmaceutical imaging," Proc IEEE, vol. 76, no. 9, pp. 1079-1094.
Jaszczak R.J., Murphy P.H., Huard D., Burdine J.A. (1977): Radionuclide emission computed tomography of the head with Tc-99m and a scintillation camera. Journal of Nuclear Medicine and Institute Physics, vol. 18, no. 4 pp. 373
Jernigan TI, Sargent T, Pfefferbaum A, Kusubov N, Stahl SM. (1985): 18Fluorodeoxyglucose PET in schizophrenia. Psychiatry Research; 16:317- 3219.
Jurjus GJ, et al (1998): Developmental brain anomalies in schizophrenia and bipolar disorder: A controlled MRI study. Journal of Neuropsychiatry 5:375-378.
Kamel M, Sadek A, El-Banouby M, Khalil S (1996) : SPECT in positive versus negative schizophrenia. Thesis presented by Salam H. Khalil for Master Degree . Faculty of Medicine. Ain Shams University
Kapur S, Remington G, Jones C, et al (1996): High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: A PET study. American Journal of Psychiatry 153:948-950
Karson C, et al (1991): The brain stem reticular formation in schizophrenia. Psychiatry 40:31-48
Kasper S, Tauscher J, Kufferle B, Barnas C, Pezawas L, Quiner S. (1999): Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience; 249 Suppl 4:83-9.
Kato T, Shioiri T, Murashita J, et al (1995): Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia. Psychiatry Research 61:151-160
Keshavan MS, Pettegrew JW, Panchalingam K, et al (1991): Phosphorus 31 magnetic resonance spectroscopy detects altered brain metabolism before onset of schizophrenia. Archive of Psychiatry 48:1112-1113
Keshavan MS, Rosenberg DR (1999): New trends in developmental neuroimaging in psychiatry. Progress Neuropsychopharmacology Biological Psychiatry. (4):557-60.
Kety SS ,Woodford RB, Harme M H, Freyhan FA, Appei KE, Schmidt CF (1948): Cerebral blood flow and metabolism in schizophrenia: the effects of barbiturate seminarcosis, insulin coma and electroshock. American Journal of Psychiatry. 104:765-770.
Kishimoto H, Kuwahara H, Ohno S, Takazu 0, Harna Y, Sato C, Lshii T, Nomura Y, Fujita H, Miyauchi T, Matsushita M, Yokoi S, lio M. (1987): Three subtypes of chronic schizophrenia identified using 11 C-glucose positron emission tomography. Psychiatry Research; 21:285-292.
Kishimoto H, Yamada K, Iseki E, Kosaka K, Okoshi (1998): Brain imaging of affective disorders and schizophrenia. Psychiatry and Clinical Neurosciences; 52 Suppl: 5212-4
Kling AS, Metter EJ, Riege WH, Kuhi DE (1986): Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. American Journal of Psychiatry; 143:175-180.
Krishnan (1999): Brain imaging correlates. Journal Clinical Psychiatry.;60 Suppl 15:50-4. .
Kugayar A, Fujita M, Innis RB (2000): Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders. Annals Nuclear Medicine. (1):1-9.
Kuhl D.E. and R.Q. Edwards (1963): "Image separation radioisotope scanning," Radiology , vol 80, pp. 653-662.
Kurachi M,Kobayashi K, Matsubara R, Hiramatsu H, Yamaguchi N, Matsoda H, Maeda T, Hisada K (1985): Regional cerebral blood flow in schizophrenic disorders, European Neurology. 24:176-181.
Kwong KK, Belliveau JW, Chesler DA, et al (1992): Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proceedings of the National Academy of Sciences of the United States of America 89:5675-5679
Laruelle M (2000):The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Research. Brain Research Reviews, 31(2-3):371-84
Laruelle M, Abi-Dargham A (1999): Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. Journal of Psychopharmacology. (4):358-71.
Laruelle M, Abi-Dargham A, van Dyck C, Gil R, D'Souza DC, Krystal J, Seibyl J, Baldwin R, Innis R (2000): Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT. Biological Psychiatry. (5):371-9.
�Laruelle M, D'Souza CD, Baldwin RM, Abi-Dargham A, Kanes SJ, Fingado CL, Seibyl JP, Zoghbi SS, Bowers MB, Jatlow P, Charney DS, Innis RB (1997): Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology 17:162
Lass P, Romanowicz G, Mizan K, Bandurski T, Afeltowicz Z, Lyczak P (1999): [Tomographic cerebral blood flow scanning in diagnosis of psychiatric disorders]. Psychiatry Polish. 33(4):601-8.
Le TH, Hu X (1996): Retrospective estimation and correction of physiological artifacts in fMRI by direct extraction of physiological activity from MR data. Magnetic Resonance in Medicine 35:290-298
Lee SM, Yip PK, Jeng JS, Lo HJ, Chang M (1999): Spontaneous oscillations of cerebral blood flow velocity in the middle cerebral arteries of normal subjects and schizophrenic patients. Psychiatry Research; 92(2-3):93-102
Lim KO, Pauly J, Webb P, et al (1994): Short TE phosphorus spectroscopy using a spin-echo pulse. Magnetic Resonance in Medicine 32:98-103
Longworth C Honey G and Sharma T (1999): Functional magnetic resonance imaging in neuropsychiatry BMJ; 319:1551-1554
�Maier M, Ron MA (1996): Hippocampal age-related changes in schizophrenia: A proton magnetic resonance spectroscopy study. Schizophrenia Research 22:5-17
Maier M, Ron MA, Barker GJ, et al (1995): Proton magnetic resonance spectroscopy: An in vivo method of estimating hippocampal neuronal depletion in schizophrenia. Psychological Medicine. 25:1201-1209
Malison RT, Best S, van Dyck C, McCance E, Wallace E, Laruelle M, Baldwin R, Seibyl J, Price L, Kosten T, Innis R (1998): Elevated striatal dopamine transporters in acute cocaine abstinence as measured by [123I]b-CIT SPECT. American Journal of Psychiatry 155:832
Mathew RJ, Duncun GC, Weinman MI, Barr Dl (1982):Regional cerebral blood flow in schizophrenia. Archive of General Psychiatry; 39:1121-1124.
Mathew RJ, Meyer JS, Francis DJ, Schoolar JC, Weinman M, Mortel KF (1998): Regional cerebral blood flow in schizophrenia: a preliminary report. American Journal of Psychiatry, 138:112-113
Mathew RJ, Wilson WH, Tant SR, Robinson 1, Prakash R (1998):Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia. Archive of General Psychiatry; 45:542-549.
McClure RJ. , Keshavan MS, Pettegrew JW.(1998): Chemical And Physiologic Brain Imaging In Schizophrenia. Psychiatric Clinics of North America Volume 21 No1
McGuire PK, Silbersweig DA, Wright I, et al (1996): The neural correlates of inner speech and auditory verbal imagery in schizophrenia: Relationship to auditory verbal hallucinations. British Journal of Psychiatry 169:148-159
Meltzer CC (1999): Neuropharmacology and receptor studies in the elderly. Journal of Geriatric Psychiatry and Neurology. (3):137-49. .
Min SK, An SK, Jon DI, Lee JD (1999): Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naive schizophrenic patients: a high-resolution SPECT study. Psychiatry Research. 90(3):159-68.
Minkowski K (1998) : The study of regional cerebral blood flow in psychiatric disorders. Psychiatry Polland .32(3):341-6.
Mozley LH, Gur RC, Gur RE, et al (1996): Relationships between verbal memory performance and the cerebral distribution of fluorodeoxyglucose in patients with schizophrenia. Biological Psychiatry 40:443-451
Myers R, Hume S, Bloomfield P , Jones T (1999):� Radio-imaging� in small animals Journal of Psychopharmacology ;13(4):352-7.
Nakashima Y, Momose T, Sano I, et al (1994): Cortical control of saccade in normal and schizophrenic subjects: A PET study using a task-evoked rCBF paradigm. Schizophrenia Research 12:259-264
Nasrallah HA, Skinner TE, Schmalbrock P, et al (1994): Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: A pilot study. British Journal of Psychiatry 165:481-485.
Nohara S, Suzuki M, Kurachi M, Yamashita I, Matsui M, Seto H, Saitoh O (2000): Neural correlates of memory organization deficits in schizophrenia. A single photon emission computed tomography study with 99mTc-ethyl-cysteinate dimer during a verbal learning task. Schizophrenia Research 5;42(3):209-22.
Nordstrom AL, Farde L, Nyberg S, et al (1995): D1 , D2 , and 5-HT2 Receptor occupancy in relation to clozapine serum concentration: A PET study of schizophrenic patients. American Journal of Psychiatry 152:1444-1449.
Nyberg S, Farde L, Halldin C (1996): Test-retest reliability of central [11 C]raclopride binding at high D2 receptor occupancy: A PET study in haloperidol-treated patients. Psychiatry Research (Neuroimaging) 67:163-171.
O'Callaghan EO, Redmond O, Ennis R, et al (1991): Initial investigation of the left temporopariet al region in schizophrenia by 31P magnetic resonance spectroscopy. Biological Psychiatry 29:1149-1152.
Ogawa S, Lee TM, Nayak AS, et al (1990): Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magnetic Resonance in Medicine 14:68-78.
Okubo Y, Suhara T, Suzuki K et al (2000): Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography. Life Science; 66(25):2455-64.
Othmer E, Othmer J. P., Othmer S. C. (1998): Brain Functions and Psychiatric Disorders, A Clinical View : Psychiatric Clinics of North America, Volume 21, Number 3, 517-566.
P.V. Harper, K.A. Lathrop, F. Jaminez, R. Fink, A. Gottschalk (1965): "Technetium-99m as a scanning agent," Radiology, vol. 85, pp. 101-109.
Parellada E, Catafau AM, Bernardo M, Lomena F, Catarineu S, Gonzalez-Monclus E (1998): The resting and activation issue of hypofrontality: a single photon emission computed tomography study in neuroleptic-naive and neuroleptic-free schizophrenic female patients. Biological Psychiatry, 44(8):787-90.
Paulman RC, Devous MD, Gregory RR, Herman JH, Jennings I, Bonte FI,Nasrallah HA, Raese 10 (1990): Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment ofschizophrenic brain function. Biological Psychiatry; 27:377- 399.
Pendas R, Boget T, Lomena F et al (2000) : Brain perfusion and neuropsychological changes in schizophrenic patients after cognitive rehabilitation. Psychiatry Research 10;98(2):127-32.
Pettegrew JW, Keshavan MS, Panchalingam K, et al (1991): Alterations in brain high-energy phosphate and phospholipid metabolism in first episode, drug-naive schizophrenia: A pilot study of the dorsal prefrontal cortex by in vivo 31P NMR spectroscopy. Archive of General Psychiatry 48:563-568.
Pickar D, Su T-P, Weinberger DR, et al (1996): Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients. American Journal of Psychiatry 153:1571-1578.
R.E. Coleman, R.A. Blinder, R.J. Jaszczak (1986): "Single Photon Emission Computed Tomography (SPECT) Part II: Clinical Applications?, Invasive Radiology, vol. 21, no. 1, pp. 1- 11.
Raz S, Raz N (1990): Structural brain abnormalities in the major psychoses: A quantitative review of the evidence from computerized imaging. Psychology Bulletin. 108:93-108.
Renshaw PF, Yurgelun-Todd DA, Cohen BM (1994): Greater hemodynamic response to photic stimulation in schizophrenic patients: An echo planar MRI study. American Journal of Psychiatry 151:1493-1495.
Renshaw PF, Yurgelun-Todd DA, Tohen M, et al (1995): Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. American Journal of Psychiatry 152:444-446
Sabri O, Erkwoh R, Schreckenberger M, Owega A, Sass H, Buell U (1997): Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet; 349(9067):1735-1739
Sachdev P, Brodaty H, Rose N, Cathcart S (1999): Schizophrenia with onset after age 50 years. 2: Neurological, neuropsychological and MRI investigation. British Journal of Psychiatry; 175:416-21
Sagawa K, Kawakatsu S., ShibuyaI Oiji A, Morinobu S, Komatani A, Yazaki M, Totsuka S (1990): Correlation of regional cerebral blood flow with performance on neuropsychological tests in schizophrenic patients. Schizophrenia Research. 3:241-246.
Sanders JA (1995): Magnetic resonance spectroscopy. In Orrison WW, et al (eds): Functional brain imaging. St Louis, Mosby, pp 419-467.
Santosh PJ (2000): Neuroimaging in child and adolescent psychiatric disorders. Archives of Disease in Childhood. 82(5): 412-9.
Sedvall G, Farde L (1995): Chemical brain anatomy in schizophrenia. Lancet 346:743-749.
Serra-Mestres J, Gregory CA, Tandon S, Stansfield AJ, Kemp PM, McKenna PJ (2000): Simple schizophrenia revisited: a clinical, neuropsychological, and neuroimaging analysis of nine cases. Schizophrenia Bulletin; 26(2):479-93.
Shenton ME, et al (1992): Left-lateralized temporal lobe abnormalities in schizophrenia and their relationship to thought disorder: A computerized, quantitative MRI study. New England Journal of Medicine 327:604-612.
Sheppard G, Gruyzelier J, Manchanda R, Hirsch SR (1983): 1 50- Positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients. Lancet, 2:1448-1452.
Shioiri T, Hamakawa H, Kato T, et al (1996): Proton magnetic resonance spectroscopy of the basal ganglia in patients with schizophrenia: A preliminary report. Schizophrenia Research 22:19-26.
Silbersweig DA, Stern E, Frith C, et al (1995): A functional neuroanatomy of hallucinations in schizophrenia. Nature 378:176-179
Stanley JA, Drost DJ, Williamson PC, et al (1995): The use of a priori knowledge to quantify short echo in vivo 1 H MR spectra. Magnetic Resonance in Medicine 34:17-24 .
Stanley JA, Williamson PC, Drost DJ, et al (1995): An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Archive of Psychiatry 52:399-406.
Stanley JA, Williamson PC, Drost DJ, et al (1996): An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. Schizophrenia Bulletin 22:597-609.
Stein DJ, Van Heerden B, Wessels CJ, Van Kradenburg J, Warwick J, Wasserman HJ (1999): Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor. Prog Neuropsychopharmacol Biological Psychiatry. 23(6):1079-99.
Steinberg JL, Devous MD Sr, Paulman RG (1996): Wisconsin card sorting activated regional cerebral blood flow in first break and chronic schizophrenic patients and normal controls. Schizophrenia Research; 19(2-3):177-87.
Steinberg JL, Devous MD SR, Paulman RG, and Gregory RR (1995): Regional cerebral blood flow in first break and chronic schizophrenic patients and normal controls. Schizophrenia Research. 17(3):229-240.
Suddath RL, Casanova MF, Goldberg TE (1989): Temporal lobe pathology in schizophrenia: A quantitative magnetic resonance imaging study. American Journal of Psychiatry 146:464-472.
Swanson CL Jr, Mozley LH, Gur RE (1997): Positron emission tomography studies of cerebral metabolism and blood flow in schizophrenia. In Krishnan KRR, Doraiswamy PM (editorials) : Brain Imaging in Clinical Psychiatry. Marcel Dekker, pp 401-424.
Szechtman H, Nahmias C, Carnett S, Firnau G, Brown CM, Kapian RD, Clegborn JM (1988): Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Archive of General Psychiatry, 45:523-532.
Tamminga C (1999): Glutamatergic aspects of schizophrenia. British Journal of Psychiatry Suppl; (37):12-5.
Toone BK, Okocha CI, Sivakumar K, Syed GM (2000): Changes in regional cerebral blood flow due to cognitive activation among patients with schizophrenia. British Journal of Psychiatry; 177:222-8.
Torrey EF, et al (1994): Schizophrenia and manic-depressive disorder. New York, Harper Collins .
Turetsky B, et al (1995): Frontal and temporal lobe brain volumes in schizophrenia. Archive of Psychiatry 52:1061-1070.
Urenjak J, Williams SR, Gadian DG, et al (1992): Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. Journal of Neurochemistry 59:55-61.
Verhoeff NP (1999): Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders. Psychopharmacology (Berl). 147(3):217-49 .
Volkow ND, Brodie JD, Wolf AP, Angrist B, Russell J, Cancro R (1986): Brain metabolism in patients with schizophrenia before and during neuroleptic administration. Journal of Neurology, Neurosurgery and Psychiatry, 49:1199-1202.
Volkow ND, Wang G-J, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, Hitzemann R, Shea CE (1997): Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386:827.
Voltz H-P, Rzanny R, May S, et al (1997): 31P Magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique--preliminary findings. Biological Psychiatry 41:644-648.
Volz H, Gaser C, Hager F, Rzanny R, Ponisch J, Mentzel H, Kaiser WA, Sauer H (1999): Decreased frontal activation in schizophrenics during stimulation with the continuous performance test a functional magnetic resonance imaging study. European Psychiatry (1):17-24.
Waddington JL (1984): Ventricular enlargement in schizophrenia and the historical studies of John Haslam. American Journal of Psychiatry 141:1640
Weight DG. Bigler ED (1998): Diagnostic Dilemmas, Part II; Neuroimaging In Psychiatry. Psychiatric Clinics of North America. Volume 21No. 4.
WeightRJ, Keshavan MS.and Pettegrew JW.(1998): Chemical And Physiologic Brain Imaging inSchizophrenia Psychiatric Clinics of North America Volume 21 No. 4.
Weinberger DR, Berman KF, Illowsky BP (1988): Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: III. A new cohort and evidence for a monoaminergic mechanism. Archive of Psychiatry 45:609-615.
Weinberger DR, Berman KF, Zec RF (1986): Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral blood flow (rCBF) evidence. Archive of Psychiatry 43:114-124.
Wenz F, Schad LR, Knopp MV, Baudendistel KT, Flomer F, Schroder J, et al (1994): Functional magnetic resonance imaging at 1.5 T: activation pattern in schizophrenic patients receiving neuroleptic medication. Journal of Magnetic Resonance Imaging; 12: 975-982.
Wenz F, Schad LR, Knopp MV, et al (1994): Functional magnetic resonance imaging at 1.5 T: Activation pattern in schizophrenic patients receiving neuroleptic medication. Journal of Magnetic Resonance Imaging 12:975-982.
Wong DF, Wagner HN, Tune LE, et al (1986): Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 234:1558-1563.
Woodruff PW, Wright IC, Bullmore ET, Brammer M, Howard RJ, Williams SC, et al. (1997): Auditory hallucinations and the temporal cortical response to speech in schizophrenia: a functional magnetic resonance imaging study. American Journal of Psychiatry; 154: 1676-168.
Yurgelun-Todd DA, Renshaw PF (1999): Applications of functional MR imaging to research in psychiatry. Neuroimaging Clinics of North America. (2): 295-308.
Yurgelun-Todd DA, Renshaw PF, Gruber SA, et al (1996): Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophrenia Research 19:55-59.
Yurgelun-Todd DA, Waternaux CM, Cohen BM, et al (1996): Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. American Journal of Psychiatry 153:200-205.
Zakzanis KK, Hansen KT (1998): Dopamine D2 densities and the schizophrenic brain. Schizophrenia Research. 17;32(3):201-6.
Zakzanis KK, Poulin P, Hansen KT, Jolic D (2000): Searching the schizophrenic brain for temporal lobe deficits: a systematic review and meta-analysis. Psychological Medicine (3):491-504.
Hosted by www.Geocities.ws

1